Akero Therapeutics Inc (DE:0K4)
FRANKFURT:0K4
Holding DE:0K4?
Track your performance easily

Akero Therapeutics (0K4) Financial Statements

2 Followers

Akero Therapeutics Financial Overview

Akero Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Akero Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is €-1.10. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -71.46M$ -54.76M$ -52.35M$ -54.29M$ -38.77M
EBITDA$ -71.29M$ -51.68M$ -52.35M$ -54.29M$ -38.77M
Net Income Common Stockholders$ -72.70M$ -55.99M$ -53.34M$ -55.19M$ -39.66M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 717.25M$ 760.19M$ 903.66M$ 550.01M$ 554.73M
Total Assets$ 817.55M$ 865.04M$ 912.24M$ 580.27M$ 635.33M
Total Debt$ 35.73M$ 35.64M$ 35.55M$ 25.78M$ 25.73M
Net Debt$ -681.52M$ -724.56M$ -868.11M$ -524.23M$ -529.00M
Total Liabilities$ 79.22M$ 66.98M$ 65.99M$ 44.97M$ 52.20M
Stockholders Equity$ 738.33M$ 798.07M$ 846.25M$ 535.31M$ 583.13M
Cash Flow-
Free Cash Flow$ -70.42M$ -57.45M$ -35.14M$ -48.63M$ -49.72M
Operating Cash Flow$ -70.42M$ -57.45M$ -35.14M$ -48.63M$ -49.72M
Investing Cash Flow$ 73.07M$ -255.90M$ 57.85M$ 12.79M$ -125.70M
Financing Cash Flow$ 3.07M$ -150.00K$ 366.94M$ 502.00K$ 806.00K
Currency in USD

Akero Therapeutics Earnings and Revenue History

Akero Therapeutics Debt to Assets

Akero Therapeutics Cash Flow

Akero Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis